Tcw Group Inc Sarepta Therapeutics, Inc. Transaction History

Tcw Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$72.25 - $168.95 $5.72 Million - $13.4 Million	-79,191 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$125.56 - $178.74 $5.12 Million - $7.29 Million	40,763 Added 106.08%	79,191 $13.5 Million
Q3 2020 Oct 30, 2020	SELL	$127.12 - $172.34 $825,517 - $1.12 Million	-6,494 Reduced 14.46%	38,428 $5.4 Million
Q2 2020 Aug 05, 2020	SELL	$93.0 - $171.7 $19,809 - $36,572	-213 Reduced 0.47%	44,922 $7.2 Million
Q1 2020 May 05, 2020	BUY	$82.38 - $131.64 $3.72 Million - $5.94 Million	45,135 New	45,135 $4.42 Million

547

87M

3.69M

1.79M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.85B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

Stay updated on Tcw Group Inc with notifications on news.